Your browser doesn't support javascript.
loading
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
Bernard, B F; Krenning, E; Breeman, W A; Visser, T J; Bakker, W H; Srinivasan, A; de Jong, M.
Afiliação
  • Bernard BF; Department of Nuclear Medicine, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Nucl Med Commun ; 21(11): 1079-85, 2000 Nov.
Article em En | MEDLINE | ID: mdl-11192715
ABSTRACT
We have evaluated the usefulness of the rat pancreatic CA20948 tumour as an in vitro cell culture model and as an in vivo model in Lewis rats comparing different radiolabelled peptides for receptor-targeted scintigraphy. In vitro the receptor-specific uptake and internalization of different radiolabelled analogues of somatostatin, bombesin, substance P and cholecystokinin were demonstrated. Analogues were selected based on high-affinity binding to their respective receptors. Their uptake and internalization in CA20948 cells were compared to these processes in AR42J cells, a well-known rat pancreatic tumour cell line used for peptide-receptor studies. Receptor-specific internalization, which was blocked by excess unlabelled peptide analogue, was found in both the CA20948 and AR42J cells for all the peptide analogues tested. This indicates specific receptor expression for all the different peptides, making these cells highly suitable for peptide studies. Internalization of the different peptides was as follows, in increasing order [111In-DOTA0]CCK < [111In-DTPA0,Arg1]substance P < [111In-DTPA0]octreotide < [111In-DTPA0,Pro1,Tyr4]bombesin. Internalization appeared to be time and temperature dependent. In accordance with the in vitro experiments, receptor-specific uptake of all the peptide analogues was also found in vivo in the solid CA20948 tumour. The in vivo tumour uptake of [111n-DTPA0]octreotide was the highest amongst the peptides tested, the order of tumour uptake being [111In-DTPA0]octreotide >[111In-DTPA0,Pro1,Tyr4]bombesin >[111In-DTPA0,Arg1]substance P > [111In-DOTA0]CCK, which is different from the in vitro findings and points to either different receptor numbers on the tumour cells for the different peptide receptors in vitro and in vivo or to differences between the peptides with regard to metabolic stability. It can be concluded that the CA20948 tumour, both in cell culture and as a solid tumour in rats, is a very useful model for peptide receptor scintigraphy and radionuclide therapy studies.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Peptídeos / Receptores de Peptídeos / Compostos Radiofarmacêuticos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nucl Med Commun Ano de publicação: 2000 Tipo de documento: Article País de afiliação: Holanda
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Peptídeos / Receptores de Peptídeos / Compostos Radiofarmacêuticos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nucl Med Commun Ano de publicação: 2000 Tipo de documento: Article País de afiliação: Holanda